HOUSE AMENDED

 

PRIOR PRINTER'S NOS. 1120, 1250

PRINTER'S NO.  1304

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

SENATE BILL

 

No.

1006

Session of

2011

  

  

INTRODUCED BY VOGEL, ROBBINS, RAFFERTY, ARGALL, SOLOBAY, ALLOWAY, YAW, ORIE, BAKER, FONTANA, ERICKSON, FOLMER, PILEGGI, COSTA, TOMLINSON, WASHINGTON, FARNESE, BOSCOLA, HUGHES, CORMAN, BLAKE, BRUBAKER, SCHWANK AND MENSCH, APRIL 28, 2011

  

  

AS AMENDED ON SECOND CONSIDERATION, HOUSE OF REPRESENTATIVES, JUNE 8, 2011   

  

  

  

AN ACT

  

1

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

2

"An act relating to the manufacture, sale and possession of

3

controlled substances, other drugs, devices and cosmetics;

4

conferring powers on the courts and the secretary and

5

Department of Health, and a newly created Pennsylvania Drug,

6

Device and Cosmetic Board; establishing schedules of

7

controlled substances; providing penalties; requiring

8

registration of persons engaged in the drug trade and for the

9

revocation or suspension of certain licenses and

10

registrations; and repealing an act," further providing for

11

Schedule I controlled substances.

12

The General Assembly of the Commonwealth of Pennsylvania

13

hereby enacts as follows:

14

Section 1.  Section 4(1) of the act of April 14, 1972

15

(P.L.233, No.64), known as The Controlled Substance, Drug,

16

Device and Cosmetic Act, amended November 24, 1999 (P.L.894,

17

No.55), is amended to read:

18

Section 4.  Schedules of Controlled Substances.--The

19

following schedules include the controlled substances listed or

20

to be listed by whatever official name, common or usual name,

 


1

chemical name, or trade name designated.

2

(1)  Schedule I--In determining that a substance comes within

3

this schedule, the secretary shall find: a high potential for

4

abuse, no currently accepted medical use in the United States,

5

and a lack of accepted safety for use under medical supervision.

6

The following controlled substances are included in this

7

schedule:

8

(i)  Any of the following opiates, including their isomers,

9

esters, ethers, salts, and salts of isomers, esters, and ethers,

10

unless specifically excepted, whenever the existence of such

11

isomers, esters, ethers and salts is possible within the

12

specific chemical designation:

13

 1.  Acetylmethadol.

14

 2.  Allylprodine.

15

 3.  Alphacetylmethadol.

16

 4.  Alphameprodine.

17

 5.  Alphamethadol.

18

 6.  Benzethidine.

19

 7.  Betacetylmethadol.

20

 8.  Betameprodine.

21

 9.  Betamethadol.

22

10.  Betaprodine.

23

11.  Clonitazene.

24

12.  Dextromoramide.

25

13.  Dextrorphan (except its methylether).

26

14.  Diampromide.

27

15.  Diethylthiambutene.

28

16.  Dimenoxadol.

29

17.  Dimepheptanol.

30

18.  Dimethylthiambutene.

- 2 -

 


1

19.  Dioxaphetyl butyrate.

2

20.  Dipipanone.

3

21.  Ethylmethylthiambutene.

4

22.  Etonitazene.

5

23.  Etoxeridine.

6

24.  Furethidine.

7

25.  Hydroxypethidine.

8

26.  Ketobemidone.

9

27.  Levomoramide.

10

28.  Levophenacylmorphan.

11

29.  Morpheridine.

12

30.  Noracymethadol.

13

31.  Norlevorphanol.

14

32.  Normethadone.

15

33.  Norpipanone.

16

34.  Phenadoxone.

17

35.  Phenampromide.

18

36.  Phenomorphan.

19

37.  Phenoperidine.

20

38.  Piritramide.

21

39.  Proheptazine.

22

40.  Properidine.

23

41.  Racemoramide.

24

42.  Trimeperidine.

25

(ii)  Any of the following opium derivatives, their salts,

26

isomers and salts of isomers, unless specifically excepted,

27

whenever the existence of such salts, isomers and salts of

28

isomers is possible within the specific chemical designation:

29

1.  Acetorphine.

30

2.  Acetyldihydrocodeine.

- 3 -

 


1

3.  Benzylmorphine.

2

4.  Codeine methylbromide.

3

5.  Codeine-N-Oxide.

4

6.  Cyprenorphine.

5

7.  Desomorphine.

6

8.  Dihydromorphine.

7

9.  Etorphine.

8

10.  Heroin.

9

11.  Hydromorphinol.

10

12.  Methyldesorphine.

11

13.  Methylhydromorphine.

12

14.  Morphine methylbromide.

13

15.  Morphine methylsulfonate.

14

16.  Morphine-N-Oxide.

15

17.  Myrophine.

16

18.  Nicocodeine.

17

19.  Nicomorphine.

18

20.  Normorphine.

19

21.  Pholcodine.

20

22.  Thebacon.

21

(iii)  Any material, compound, mixture, or preparation which

22

contains any quantity of the following hallucinogenic

23

substances, their salts, isomers, and salts of isomers, unless

24

specifically excepted, whenever the existence of such salts,

25

isomers, and salts of isomers is possible within the specific

26

chemical designation:

27

1.  3,4-methylenedioxy amphetamine.

28

2.  5-methoxy-3,4-methylenedioxy amphetamine.

29

3.  3,4,5-trimethoxy amphetamine.

30

4.  Bufotenine.

- 4 -

 


1

5.  Diethyltryptamine.

2

6.  Dimethyltryptamine.

3

7.  4-methyl-2,5-dimethoxyamphetamine.

4

8.  Ibogaine.

5

9.  Lysergic acid diethylamide.

6

10.  Mescaline.

7

11.  Peyote.

8

12.  N-ethyl-3-piperidyl benzilate.

9

13.  N-methyl-3-piperidyl benzilate.

10

14.  Psilocybin.

11

15.  Psilocyn.

12

16.  Tetrahydrocannabinols.

13

17.  Salvia Divinorum.

14

18.  Salvinorin A.

15

19.  Divinorin A.

16

20.  3,4-Methylenedioxymethcathinone (Methylone).

17

21.  3,4-Methyenedioxypyrovalerone (MDPV).

18

22.  4-Methylmethcathinone (Mephedrone).

19

23.  4-Methoxymethcathinone.

20

24.  4-Fluoromethcathinone.

21

25.  3-Fluoromethcathinone.

22

(iv)  Marihuana.

23

(v)  Any material, compound, mixture or preparation which

24

contains any quantity of the following substances, including the

25

salts, isomers and salts of isomers:

26

1.  Methaqualone.

27

(vi)  Gamma hydroxybutyric acid, any salt, hydroxybutyric

28

compound, derivative or preparation of gamma hydroxybutyric

29

acid, including any isomers, esters and ethers and salts of

30

isomers, esters and ethers of gamma hydroxybutyric acid, except

- 5 -

 


1

gamma-butyrolactone (GBL), whenever the existence of such

2

isomers, esters and salts is possible within the specific

3

chemical designation. For purposes of security requirements

4

imposed by law or regulation upon registered distributors and

5

registered manufacturers, this substance when manufactured,

6

distributed or possessed in accordance with an exemption

7

approved under section 505(i) of the Federal Food, Drug, and

8

Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) shall,

9

notwithstanding any other provision of this act, be classified

10

as a controlled substance in Schedule III of this section.

11

(vii)  Synthetic cannabinoids or any material, compound,

<--

12

mixture or preparation which contains any quantity of the

13

following substances, including the salts, isomers and salts of 

<--

14

their analogues, congeners, homologues, isomers, salts and salts

<--

15

of analogues, congeners, homologues and isomers, as follows:

16

1.  CP 47,497 and homologues, 2-[(1R,3S)-3-

17

hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol).

18

2.  HU-210, [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-

19

methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo[c] chromen-1-

20

ol)].

21

3.  HU-211, (dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-6,6-

22

dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-

23

tetrahydrobenzo[c]chromen-1-ol).

24

4.  JWH-018, 1-Pentyl-3-(1-naphthoyl)indole.

25

5.  JWH-019, 1-Hexyl-3-(1-naphthoyl)indole.

26

6.  JWH-073, 1-Butyl-3-(1-naphthoyl)indole.

27

7.  JWH-200, (1-(2-morpholin-4-ylethyl)indol-3-yl)-

28

naphthalen-1-ylmethanone.

29

8.  JWH-250, 1-pentyl-3-(2-methoxyphenylacetyl)indole.

30

(viii)  Psychedelic phenethylamines, their salts, their

<--

- 6 -

 


1

isomers and the salts of analogues, congeners, homologues,

<--

2

isomers, salts and the salts of analogues, congeners, homologues

3

and isomers as follows:

4

1.  2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

5

2.  2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

6

3.  2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

7

4.  2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

8

5.  2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).

9

6.  2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-

10

T-4).

11

7.  2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

12

8.  2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

13

9.  2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

14

* * *

15

Section 2.  This act shall take effect in 60 days.

- 7 -

 


See other bills
under the
same topic